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 ABSTRACT 
 To test which, if any, of the major milk precursors 
can elicit a rapid change in the rate of mammary 
blood flow (MBF) and to define the time course and 
magnitude of such changes, 4 lactating cows were in-
fused with glucose, amino acids, or triacylglycerol into 
the external iliac artery feeding one udder half while 
iliac plasma flow (IPF) was monitored continuously 
by dye dilution. Adenosine and saline were infused as 
positive and negative controls, respectively, and insulin 
was infused to characterize the response to a centrally 
produced anabolic hormone. To test the roles of cyclo-
oxygenase, NO synthase and ATP-sensitive K (KATP) 
channels in nutrient-mediated changes in blood flow, 
their respective inhibitors—indomethacin, Nω-nitro-L-
arginine methyl ester hydrochloride (L-NAME), and 
glibenclamide—were infused simultaneously with glu-
cose. Each day, 1 infusate was given twice to each cow, 
over a 20-min period each time, separated by a 20-min 
washout period. In addition, each treatment protocol 
was administered on 2 separate days. A 73% increase 
in IPF during adenosine infusion showed that the mam-
mary vasodilatory response was quadratic in time, with 
most changes occurring in the first 5 min. Glucose infu-
sion decreased IPF by 9% in a quadratic manner, most 
rapidly in the first 5 min, indicating that a feedback 
mechanism of local blood flow control, likely through 
adenosine release, was operative in the mammary vas-
culature. Amino acid infusion increased IPF 9% in a 
linear manner, suggesting that mammary ATP utiliza-
tion was stimulated more than ATP production. This 
could reflect a stimulation of protein synthesis. Triac-
ylglycerol only tended to decrease IPF and insulin did 
not affect IPF. A lack of IPF response to glibenclamide 
indicates that KATP channels are not involved in MBF 
regulation. Indomethacin and L-NAME both depressed 
IPF. In the presence of indomethacin, glucose infusion 
caused a quadratic 9% increase in IPF. Indomethacin is 
an inhibitor of mitochondrial function, so the glucose-
induced increase in IPF was interpreted as feedback on 
mammary adenosine release from an anabolic response 
to glucose. Because NO synthase was not inhibited 
during indomethacin infusion, the feedback system is 
postulated to act through endothelial NO synthase. In 
the presence of L-NAME, glucose infusion had no effect 
on IPF, indicating that endothelial cyclooxygenase is 
not involved in glucose-induced changes in MBF. 
 Key words:   mammary blood flow ,  nitric oxide syn-
thase ,  cyclooxygenase ,  glucose 
 INTRODUCTION 
 Several tissues, including skeletal muscle (Jones and 
Berne, 1964), kidney (Haddy et al., 1958), heart (Scott 
et al., 1965), and the mammary glands (Linzell, 1974), 
have the ability to locally regulate their own blood flow 
according to metabolic activity in the tissue. A com-
bination of feedforward and feedback mechanisms has 
been postulated to link metabolic activity with blood 
flow in skeletal and cardiac muscle. In feedforward 
mechanisms, products of energy metabolism stimulate 
blood flow, and in feedback mechanisms, they inhibit 
blood flow. One example of a feedforward mechanism 
involves production of CO2 in muscle, which results in 
H+-mediated activation of ATP-sensitive K (KATP) 
channels in smooth muscle cells surrounding capillar-
ies, causing relaxation and vasodilation (Deussen et al., 
2012), presumably to improve nutrient supply for an 
elevated workload. Endothelial synthesis of the vasodi-
lator NO also appears to be involved in CO2-mediated 
hyperemia (Gurevicius et al., 1995). Another feedfor-
ward mechanism involves production of H2O2 during 
oxidative metabolism, which acts through voltage-gated 
K (KV) channels on smooth muscle cells (Rogers et al., 
2006) and cyclooxygenase (COX)-mediated prostacy-
clin (PGI2) synthesis in endothelial cells (Thengchaisri 
and Kuo, 2003) to dilate capillaries. Adenosine is a 
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feedback vasodilator that is released when intracellular 
ATP is low; it relaxes smooth muscle by activating 
KATP channels and endothelial NO synthase (Hein and 
Kuo, 1999; Deussen et al., 2012).
Adenosine, NO synthase, and PGI2 have all been 
shown to be active in the mammary vasculature of 
lactating ruminants (Oguro et al., 1982; Nielsen et al., 
1995a; Lacasse et al., 1996; Prosser et al., 1996), lead-
ing to the proposition that the mammary gland has the 
ability to locally control its own blood flow and, hence, 
arterial nutrient supply. A corollary to this proposition 
is that arterial nutrient supply should, in turn, have an 
influence on mammary blood flow (MBF) and, indeed, 
infusion of 90 g/h glucose into the external iliac artery 
supplying one udder half for 10 h reduced MBF by 
16% (Cant et al., 2002), removal of histidine from an 
AA infusion into the abomasum caused an increase in 
MBF (Bequette et al., 2000), and elevation of plasma 
triacylglycerol (TAG) by fat supplementation of the 
diet caused a reduction in MBF:milk yield ratio (Cant 
et al., 1993). Accordingly, Cant and McBride (1995) 
and Cherepanov et al. (2000) constructed mathematical 
models of nutrient utilization in the mammary glands 
in which MBF is modified locally to match energy sup-
ply with expenditure. Mechanisms by which metabolic 
activity influences MBF were not specified because 
they have not been identified. The mammary models 
simulate changes in MBF that commence immediately 
on perturbation of arterial nutrient concentrations 
but we are unaware of any experimental data that 
demonstrate short-term responses of MBF to nutrient 
supply. Cherepanov et al. (2000) point out that the 
response delay would encompass rate of vasodilator 
production, reactivity of the capillaries, and hydraulic 
characteristics of the microvasculature. Blood flow to 
several organs, including the mammary glands, in-
creases within seconds of administration of vasodilators 
into the arterial supply (Oguro et al., 1982; Rådegran 
and Hellsten, 2000). In muscle, blood flow reaches 50% 
of its maximum increase within 2 to 9 s of the onset of 
exercise (Rådegran and Saltin, 1998).
A greater understanding of the mechanisms involved 
in local regulation of mammary blood flow would allow 
predictive models to better account for variation in nu-
trient uptake and utilization for milk synthesis. To test 
which, if any, of the major milk precursors can elicit 
a rapid change in the rate of MBF, and to define the 
time course and magnitude of such changes, lactating 
cows were infused with glucose, AA, or TAG into the 
external iliac artery feeding one udder half while blood 
flow was monitored by dye dilution. Adenosine and 
saline were infused as positive and negative controls, 
respectively, and insulin was infused to characterize the 
response to a centrally produced, anabolic hormone. To 
test the roles of COX, NO synthase, and KATP chan-
nels in nutrient-mediated changes in blood flow, their 
respective inhibitors indomethacin, Nω-nitro-L-arginine 
methyl ester hydrochloride (L-NAME), and gliben-
clamide were infused simultaneously with glucose.
MATERIALS AND METHODS
Animals
All animal procedures and holding facilities were ap-
proved by the Animal Care Committee of the Univer-
sity of Guelph. Four multiparous Holstein cows, at 580 
± 29.3 kg of BW and 54 ± 8.9 DIM (±SEM) were fit-
ted with polyurethane catheters in both left and right 
subcutaneous abdominal veins (milk veins) and with 
polyethylene catheters in both iliac arteries, introduced 
through the saphenous arteries as described by Maas et 
al. (1995). The external iliac position was confirmed by 
injection of Evan’s Blue dye into the arterial catheters 
(Cant et al., 2001).
After 2 d of recovery in box stalls, cows were housed 
in tie stalls with mattresses and wood shavings. They 
were milked and fed a corn silage-based TMR (50.5% 
DM, 17.7% CP, 32.6% NDF, 3.6% fat, 1.74 Mcal of 
NEL/kg on a DM basis) twice daily at 0800 and 1800 h. 
Refusals were weighed at 0730 h daily to determine feed 
intake. Milk was sampled at each milking and analyzed 
by infrared spectroscopy for protein, fat, and lactose 
(AOAC International, 1996).
Infusion Protocols
Commencing on d 5 after surgery, cows were sub-
jected twice daily to a 95-min infusion protocol into 
one external iliac catheter, starting at 1000 or 1400 h. 
Para-aminohippuric acid (PAH; Na salt) was infused 
continuously at 100 mg/min throughout the entire 95 
min to estimate iliac plasma flow by arteriovenous di-
lution. As depicted in Figures 1, 2, 3, 4, 5, and 6, a 
treatment solution was infused for 20 min, commencing 
at 30 min of PAH infusion, and after a second baseline 
period, at 70 min of PAH infusion. The same treatment 
was infused both times. Treatments were 0.38 g/min 
of NaCl, 3 mg/min of adenosine (Sigma Chemical Co., 
St. Louis, MO), 2.2 g/min of glucose (Sigma Chemi-
cal Co.), 2.11 g/min of a complete AA mix (Table 1), 
0.87 g/min of TAG (10% Liposyn; Abbott Laboratories 
Ltd., Montreal, Quebec, Canada), 20 μg/min of insulin 
(Sigma Chemical Co.), 2.0 mg/min of indomethacin 
(Sigma Chemical Co.), 25 mg/min of L-NAME (Sigma 
Chemical Co.), or 2.0 mg/min of glibenclamide (Sigma 
Chemical Co.). Glucose and AA solutions were pre-
pared at 220 and 211 g/L, respectively. The complete 
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mix of AA (United States Biochemical, Cleveland, OH) 
was formulated to the AA profile of milk protein (Ham-
braeus, 1982), assuming 80% casein and 20% whey 
proteins, with equimolar replacement of Gln, Asn, and 
Tyr by Glu, Asp, and Phe, respectively, as previously 
described (Purdie et al., 2008). Liposyn contains 5% saf-
flower oil, 5% soybean oil, 1.2% egg phosphatides, and 
2.5% glycerol in water, where linoleic, oleic, palmitic, 
linolenic, and stearic acids account for 65.8, 17.7, 8.8, 
4.2, and 3.4% of the FA, respectively. All milk precur-
sor infusion rates were balanced to equivalent yields of 
ATP from oxidative metabolism, assuming 0.20 mol of 
ATP/g of glucose, 0.21 mol of ATP/g of AA, and 0.51 
mol of ATP/g of TAG. The 0.38 g/min NaCl infusion 
was equivalent in osmolality to the glucose infusion, at 
1.2 mOsm/L. The solutions of insulin were prepared 
daily for each cow from frozen aliquots (1 mg of insu-
lin/mL of water containing 1% BSA and 50 μL of 6 N 
HCl). All solutions were filtered for sterility through 
0.22-μm cellulose acetate filters into autoclaved poly-
propylene bottles and refrigerated overnight.
Infusate bottles were weighed frequently during in-
fusion to monitor flow rate by time-series regression. 
Infusion lines from PAH and treatment solutions were 
joined beyond the peristaltic pump via a Y-connector 
so that only one line extended to the arterial catheter. 
Both solutions were infused at 10 mL/min. To main-
tain a constant PAH infusion rate between baseline and 
treatment periods, a solution of 0.9% NaCl was also 
infused at 10 mL/min during baseline periods. Treat-
ment periods began by switching from 0.9% NaCl to 
treatment solutions without changing the total volume 
flow rate to the catheter.
Blood samples were collected continuously via peri-
staltic pump from the external iliac arterial catheter 
contralateral to infusion and the ipsilateral subcutane-
ous milk vein. Blood was collected into sealed, heparin-
ized Vacutainers (Becton Dickinson, Franklin Lakes, 
NJ) on ice through platinum-cured, silicone, peristaltic 
pump tubing attached to respective catheters. Blood 
sampling started at 21 min of PAH infusion and blood 
collection tubing was sequentially moved to new Vacu-
tainers at 24, 27, 52, 55, 67, 92, and 95 min of PAH in-
fusion, and 0, 1, 2, 3, 5, 10, 15, and 20 min of treatment 
infusion. Plasma was separated by centrifugation for 20 
min at 1,500 × g and 4°C. Plasma was transferred to 
propylene tubes and stored at −20°C until analysis was 
performed.
A subset of experiments was performed with glucose 
infusion during infusion of the blood flow inhibitors in-
domethacin, L-NAME, or glibenclamide. In this subset 
of experiments, PAH was infused continuously for 74 
min and the inhibitor was infused from 30 to 74 min of 
PAH infusion. Glucose was infused between 44 and 64 
min of PAH infusion. The fraction collector for blood 
sample collection was moved to new Vacutainers at 20, 
40, 43, 66, 68, and 71 min of PAH infusion and at 0, 1, 
2, 3, 5, 8, 13, and 18 min of glucose infusion.
Sample Analysis and Calculations
Concentrations of PAH in plasma and infusates, and 
of glucose, TAG, and NEFA in plasma were analyzed as 
described by Cant et al. (2001). Plasma α-amino-N was 
determined according to Evans et al. (1993). Insulin 
was assayed in plasma by 125I radioimmunoassay (Diag-
nostic Products Corp., Los Angeles, CA).
Rate of plasma flow in the external iliac artery for 
each sampling time was calculated as the quotient of 
PAH infusion rate and venoarterial concentration dif-
ference. Because of difficulties associated with placing 
catheters in the external pudendal artery supplying 
each udder half, we chose a simpler approach to arte-
rial catheterization in the external iliac. However, ap-
proximately 20% of external iliac plasma does not flow 
to the mammary glands and flows to the hind limb via 
the femoral artery (Bequette et al., 2001; Cant et al., 
2002). External iliac plasma flow (IPF) was compared 
with hind leg flow in one cow fitted with a polyethylene 
catheter in a tarsal vein upon completion of experi-
ments. A baseline arterial blood sample was obtained, 
and then PAH was rapidly injected into the arterial 
catheter, and blood was collected from the tarsal vein 
via syringe pump for exactly 1 min. The procedure was 
repeated several times. The tip of the arterial catheter 
was then pulled past the deep femoral artery (through 
which the mammary blood flows), as confirmed by 
Table 1. Difference between mean minimum and maximum iliac 
plasma flow (IPF, as a percentage of the baseline value) during 20-min 







Saline −0.03 0.81 0.94
Adenosine 73.4 <0.01 <0.01
Glucose −8.8 0.10 0.05
Amino acids 8.6 0.01 0.30
Triacylglycerol −7.4 0.37 0.08
Insulin −0.1 0.45 0.88
Indomethacin −37.2 <0.01 <0.01
L-NAME1 −11.9 <0.01 0.40
Glibenclamide −1.5 0.75 0.80
Glucose during    
 Indomethacin 9.3 <0.01 0.02
 L-NAME −4.8 0.43 0.22
 Glibenclamide 8.4 0.39 0.18
1Nω-nitro-L-arginine methyl ester hydrochloride.
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Evan’s Blue dye injection, and the PAH injection pro-
cedure was repeated several times. Plasma flow was 
calculated as [PAH dose (g) ÷ PAH venoarterial differ-
ence (g/L)] ÷ sample time (min). Average plasma flow 
to the hind leg was 21% of IPF.
Arterial concentrations of infused metabolites on the 
infused side were calculated as contralateral arterial 
concentration (mM) + infusion rate (mmol/min) ÷ 
IPF (L/min).
Statistical Analysis
Each 95- or 74-min test of each treatment was con-
ducted twice on each of 4 cows for a total of 8 replica-
tions. The 95-min tests included 9 treatments and the 
74-min tests 3 treatments, for a total of 12 treatments. 
Infusion protocols commenced at 1000 and 1400 h on 
each of 12 consecutive days.
Changes in IPF at each sampling time in the 95-min 
protocol were calculated relative to the first baseline 
period (average of values at 24, 27, and 30 min of PAH 
infusion). For those time-course curves where IPF did 
not return to the first baseline by 70 min of PAH infu-
sion, changes in IPF during the second, 20-min, treat-
ment period were also calculated relative to the value 
at 70 min. Changes in IPF in the 74-min inhibitor + 
glucose protocol were calculated relative to the average 
of values at 43 and 46 min of PAH infusion (13 and 
16 min of inhibitor infusion). For each treatment, rela-
tive IPF values (Yijk) were subjected to ANOVA using 
PROC MIXED of SAS (version 9; SAS Institute Inc., 
Cary, NC) according to
Yijk = μ + timei + cowj + repk + time × cowij + εijk,
where μ = overall mean, timei = repeated time effect 
(i = 1 to 10 or 21 for values normalized to the first or 
second baselines, respectively), cowj = cow effect (j = 
1 to 4), repk = replication effect (k = 1 to 2), and εijk 
= experimental error. Covariance in repeated measures 
on the same subject was accommodated with a first-
order, autoregressive structure. Linear and quadratic 
effects of time within each 20-min infusion period were 
estimated using coefficients calculated in PROC IML of 
SAS (SAS Institute Inc.). Significance of contrasts was 
declared at P ≤ 0.05 and trends at 0.05 < P ≤ 0.10.
RESULTS
Over the 12 d of the experiment, the cows consumed 
17.7 ± 1.1 (SE) kg/d of DM, and produced 31.9 ± 1.4 
kg/d of milk containing 4.17 ± 0.09% fat, 2.71 ± 0.16% 
protein, and 4.87 ± 0.04% lactose. According to NRC 
(2001) equations for NEL requirements, cows were in an 
NEL balance of −2.0 Mcal/d.
Saline and Adenosine Infusions
Infusion of hypertonic solutions has been shown to 
decrease vascular resistance in contracting muscles 
(Mellander and Lundvall, 1971). To test the possibility 
that effects of nutrient infusion were due to changes 
in osmolality, 0.38 g/min of NaCl was infused into the 
external iliac artery. Iliac plasma flow was not signifi-
cantly affected throughout the 95-min infusion protocol 
(P = 0.33) and the hypertonic NaCl did not cause a 
linear or quadratic change in IPF during infusion (P > 
0.81; Figure 1; Table 1). The lack of response to NaCl 
indicates that tonicity of the milk precursor solutions 
would not affect IPF in our experiment.
Adenosine is a potent vasodilator in many tissues of 
the body (Haddy and Scott, 1968) and the mammary 
glands are no exception. Because Prosser et al. (1996) 
demonstrated a 250% increase in MBF within 15 min 
Figure 1. Time course of iliac plasma flows (IPF) as a percent-
age of the 0-min value during arterial saline (A) and adenosine (B) 
infusions. Shaded bars indicate the first and second infusion periods. 
P-values indicate linear and quadratic effects of time during the infu-
sion periods.
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of adenosine infusion into the external pudendal artery 
of goats, we chose adenosine as a positive control to 
test the validity of measuring minute-to-minute blood 
flow changes by arteriovenous dilution of PAH with an 
automated venous sampling technique. Both linear and 
quadratic effects of time on IPF were detected during 
adenosine infusion (P < 0.01; Table 1) but the qua-
dratic effect was most apparent (Figure 1), where the 
majority of the 73% increase in IPF occurred within 
the first 5 min of infusion. Thereafter, during adenos-
ine infusion, IPF remained elevated. Furthermore, IPF 
returned to baseline values by the beginning of the 
second infusion period. These results indicate that the 
method for assessment of acute perturbations in IPF 
was adequate, and that the time-dependent response to 
constant delivery of a vasodilator is quadratic.
Milk Precursor Infusions
Infusion of glucose at 2.2 g/min caused close arterial 
concentrations of glucose to increase from an average of 
3.2 mM to a peak of 6.7 mM in the first infusion period 
and to 7.0 mM in the second (Figure 2). Concentrations 
returned to 11% above baseline in the 20-min washout 
period between infusions. During glucose infusion, IPF 
decreased by 9% in a quadratic manner (P = 0.05; Table 
1), most rapidly in the first 5 min (Figure 2). Although 
IPF was depressed at the beginning of the second infu-
sion of glucose, the infusion still caused a further decline 
in IPF. Iliac plasma flow increased upon cessation of 
both glucose infusions. The quadratic pattern of the IPF 
response to glucose is consistent with lower vasodilator 
release into the mammary vasculature.
Close arterial α-amino-N concentrations were 130% 
greater than baseline values during the 20-min infu-
sion of 2.11 g/min of AA (Figure 3) and returned to 
baseline values within 20 min of cessation of infusion. 
In contrast to the rapid and sustained decrease in IPF 
during glucose infusion, IPF increased linearly by 9% 
throughout the AA infusions (P = 0.01; Table 1).
Infusion of 0.87 g/min of TAG caused close arterial 
TAG concentrations to increase from 50 to 290 μM and 
NEFA concentrations to increase from 140 to 240 μM 
Figure 2. Time course of close arterial glucose concentrations (A) 
and iliac plasma flows (IPF) as a percentage of the 0- (solid line) 
and 40-min (dashed line) values (B) during arterial glucose infusion. 
Shaded bars indicate the first and second infusion periods. P-values in-
dicate linear and quadratic effects of time during the infusion periods.
Figure 3. Time course of close arterial α-amino N concentrations 
(A) and iliac plasma flows (IPF) as a percentage of the 0- (solid line) 
and 40-min (dashed line) values (B) during arterial amino acid in-
fusion. Shaded bars indicate the first and second infusion periods. 
P-values indicate linear and quadratic effects of time during the infu-
sion periods.
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(Figure 4). The large increase in circulating NEFA indi-
cates that the infused TAG were extensively hydrolyzed 
by lipoprotein lipase. Upon cessation of TAG infusion, 
concentrations of both TAG and NEFA returned to 
baseline levels. We detected a tendency (P = 0.08) for 
a quadratic response in IPF to TAG infusion due to a 
rapid 8% decrease in IPF during the first 5 min of the 
first infusion period, followed by a return to baseline 
IPF while TAG infusion was still ongoing. The pattern 
was not repeated during the second infusion period. 
Thus, TAG at the same ATP equivalent as glucose did 
not elicit the same IPF response.
Close arterial insulin concentrations increased from 
22 to 830 pM during the first infusion of 20 μg/min 
insulin, and from 41 to 1,068 pM during the second 
infusion (Figure 5). Plasma glucose declined from 2.7 
to 2.0 mM by 37 min of the experiment and remained 
at 2.0 mM thereafter. We observed no effect on IPF 
during either of the insulin infusion periods, whereas 
IPF declined 10% between the first and second peri-
ods.
Infusions of Blood Flow Inhibitors 
Indomethacin caused a transient 5% increase in IPF 
during the first 2 min of infusion (Figure 6A), and then 
a rapid 30% decrease in IPF over the next 5 min (P 
< 0.01; Table 1), in both infusion periods. The IPF 
remained low throughout indomethacin infusion but 
returned to baseline within 6 min of termination. When 
glucose was infused at 2.2 g/min during indomethacin 
treatment, we detected a quadratic increase in IPF to 
9% above baseline that was maintained throughout 
(Figure 6B). This increase in IPF is in contrast to the 
glucose-mediated depression of IPF observed without 
indomethacin (Figure 2).
Infusion of L-NAME caused a linear decrease in IPF 
without a return to baseline between infusion periods 
(Figure 6C). This pattern indicates that NO synthase 
is required to maintain MBF but L-NAME exhibits a 
long residence time within the circulation. Glucose did 
not affect IPF in the presence of L-NAME (Figure 6D).
Glibenclamide did not affect IPF in either of the 
2 infusion periods (Figure 6E). During glibenclamide 
treatment, glucose infusion did not elicit a decrease in 
IPF (P > 0.18; Figure 6F). However, IPF increased (P 
< 0.01) when glucose infusion ceased (Figure 6F) in 
the same manner as observed without glibenclamide 
(Figure 2).
DISCUSSION
MBF Is Locally Regulated by a Feedback Mechanism
Previous studies of nutritional perturbation of MBF 
(Cant et al., 1993, 2002; Bequette et al., 2000) have 
been interpreted as showing that nutrient concentra-
tions in blood supplying the mammary glands can 
influence the rate of blood flow to the glands (Cant 
and McBride, 1995; Cherepanov et al., 2000; Cant et 
al., 2003). Our current results show that these nutrient-
mediated changes occur within 5 min. Changes in blood 
flow could represent nutritive flow through capillaries 
under the control of local vasodilatory mechanisms, or 
nonnutritive flow through arteriovenous shunts as part 
of the autonomic nervous control of systemic arterial 
pressure. Although some evidence suggests that a por-
tion of MBF is nonnutritive (Prosser et al., 1996), the 
extent to which MBF is modulated to maintain arterial 
pressure and blood flow to other organs of the body 
remains unknown. Intravenous infusion of hypertonic 
glucose solutions may induce autonomic regulation of 
arterial blood pressure (Mostert et al., 1971) but we 
observed no effect of hypertonic saline on IPF. Thus, it 
is presumed for the following discussion that short-term 
changes in IPF in response to arterial nutrient infusions 
Figure 4. Time course of close arterial triacylglycerol (TAG) and 
NEFA concentrations (A) and iliac plasma flows (IPF) as a percent-
age of the 0-min value (B) during arterial TAG infusion. Shaded bars 
indicate the first and second infusion periods. P-values indicate linear 
and quadratic effects of time during the infusion periods.
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were indicative of local vasodilatory mechanisms in the 
mammary glands.
Both feedforward and feedback mechanisms have 
been proposed to explain the link between metabolic 
activity of a tissue and its rate of blood flow (Deussen 
et al., 2012). Feedforward mechanisms postulate that 
increased intracellular catabolism of nutrients to CO2 
and H2O is associated with a higher level of work in 
the tissue; that is, ATP expenditure. A greater nutri-
ent supply is required for this work and, to provide 
these additional nutrients, blood flow is increased by 
vasodilatory end products of catabolism (vasodilatory 
compounds; VDC) such as CO2, H
+, and H2O2. This 
mechanism presumes that nutrients are catabolized 
only when the demand for ATP arises, and not in rela-
tion to nutrient supply; otherwise, an elevated nutrient 
supply would increase blood flow via VDC. This higher 
blood flow would increase nutrient supply and catabo-
lism further, thereby increasing blood flow again. Such 
an escalation is prevented by energetic regulation of 
catabolism, including the inhibition of glycolysis by 
ATP (Depré et al., 1998) and inhibition of fatty acid 
and glucose oxidation by citrate (Hue and Taegtmeyer, 
2009). Thus, for a feedforward mechanism to work 
properly, catabolism and the resultant hyperemia only 
occur when the inhibitory effects of ATP and citrate 
are lifted as a consequence of ATP expenditure.
Feedforward mechanisms of blood flow regulation 
depend exclusively on a change in ATP expenditure 
to mediate a change in blood flow. Feedback mecha-
nisms, on the other hand, postulate that vasodilators 
such as adenosine are released into the interstitium in 
proportion to the intracellular ADP:ATP ratio so that 
a change in either ATP utilization or production causes 
blood flow to change. If ATP expenditure increases, 
ADP production and adenosine release are stimulated 
and blood flow increases, whereas if nutrient catabo-
lism increases, ADP is depleted and adenosine release 
declines, along with blood flow.
Of the 3 milk precursors tested, glucose decreased 
IPF, TAG tended to decrease IPF, and AA increased 
IPF. Each precursor, when taken up into the mammary 
epithelial cell, can be used either for anabolic produc-
tion of milk lactose, fat, or protein, which consumes 
ATP, or for catabolism to generate ATP. A feedforward 
mechanism of energetic blood flow regulation cannot 
account for the 9% decrease in IPF observed during 
glucose infusion. The feedforward mechanism requires 
a decrease in VDC release to elicit a decrease in blood 
flow, and neither an increase in lactose synthesis nor 
an increase in glucose catabolism would decrease VDC 
release. However, a feedback mechanism would result 
in lower blood flow if the glucose were catabolized to 
generate ATP and adenosine release consequently de-
clined. Because IPF decreased, the glucose results sup-
port existence of a feedback control mechanism in the 
mammary glands that is stronger than a feedforward 
effect.
During insulin infusion, glucose concentrations de-
creased to 2.0 mM, which, to remain consistent with re-
sponses to glucose infusion, should have increased IPF. 
However, IPF did not increase, suggesting an opposing 
effect of insulin. Linzell (1967) observed a decrease in 
MBF and milk yield concurrent with decreased plasma 
glucose concentrations 1 h after insulin injection into 
goats. Anabolic effects of insulin on adipose and muscle 
tissues may have caused a diversion of cardiac output 
into these other tissues. Linzell (1967) also noted that 
MBF did not decrease in all goats in response to insu-
lin. Similarly, we found a large variation in IPF during 
insulin infusion (Figure 5), indicating inconsistent re-
sponses between cows and making conclusions difficult.
Infusion of long-chain FA as TAG only tended to 
decrease IPF in a quadratic manner, suggesting that 
ATP balance was affected less by TAG than by glucose. 
Long-chain FA are not oxidized to any great extent in 
the lactating mammary gland (Rudolph et al., 2003) 
but they inhibit fat synthesis from acetate, which de-
creases ATP utilization, and stimulate lactose synthesis 
Figure 5. Time course of close arterial insulin and glucose con-
centrations (A) and iliac plasma flows (IPF) as a percentage of the 
0- (solid line) and 40-min (dashed line) values (B) during arterial 
insulin infusion. Shaded bars indicate the first and second infusion 
periods. P-values indicate linear and quadratic effects of time during 
the infusion periods.
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from glucose, which increases ATP utilization (Cant et 
al., 1993). The opposing effects on ATP utilization may 
account for the small, nonsignificant change in IPF.
The increase in IPF during AA infusion suggests that 
mammary ATP utilization was stimulated. Amino acids 
activate mammary protein synthesis (Bequette et al., 
2001), even within minutes of administration (Burgos et 
al., 2010), and protein synthesis consumes a substantial 
proportion of the mammary ATP use (Hanigan et al., 
2009). Although AA and glucose were infused to supply 
identical ATP yields when completely catabolized, the 
difference in IPF responses suggests that glucose was 
catabolized to a greater extent than AA. Stimulation 
of ATP utilization by AA could increase IPF by both 
feedforward and feedback mechanisms.
Hemodynamic responses to TAG and AA do not al-
low us to distinguish feedforward from feedback regula-
tion of IPF. However, the response to glucose was a 
Figure 6. Time course of iliac plasma flows (IPF) as a percentage of the 0- (solid line) and 40-min (dashed line) values during arterial infusion 
of indomethacin (A), glucose during indomethacin (B), Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME; C), glucose during L-NAME 
(D), glibenclamide (E), and glucose during glibenclamide (F). Shaded bars indicate the first and second infusion periods. P-values indicate linear 
and quadratic effects of time during the infusion periods.
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decrease in IPF, which can only be explained by a feed-
back mechanism. Acetate might have been a candidate 
to test the existence of feedback regulation because it 
is oxidized heavily in the mammary epithelium, but we 
have been unable to detect an effect of short-term, arte-
rial acetate infusion on mammary ATP balance (Maas 
et al., 1995; Purdie et al., 2008). Similarly, glucose 
supplementation of mammary epithelial cells in vitro 
increased intracellular ATP concentrations, whereas 
acetate supplementation did not (Appuhamy et al., 
2014).
Nitric Oxide, But Not PGI2, Mediates the  
Glucose-Induced Decrease in Mammary Blood Flow
The mechanisms by which blood flow to a tissue is 
locally regulated to match the metabolic rate of the 
tissue have not been fully elucidated. However, it is 
known that PGI2 and NO produced in the endothelium 
can play an important role. In skeletal and cardiac 
muscle, decreased partial pressure of O2 and elevated 
H2O2 as a result of oxidative metabolism activate en-
dothelial PGI2 synthesis (Thengchaisri and Kuo, 2003; 
Deussen et al., 2012) and PGI2 relaxes vascular smooth 
muscle in a cyclic AMP-dependent manner (Hellsten 
et al., 2012). Thus, PGI2 is a mediator of the feedfor-
ward link between metabolic activity and blood flow. 
Muscular catabolism also produces the VDC CO2 and 
H+, which activate endothelial NO synthesis (Deussen 
et al., 2012), as does adenosine (Hein and Kuo, 1999). 
As a mediator of both feedforward and feedback loops, 
NO acts through cyclic GMP to relax vascular smooth 
muscle (Hellsten et al., 2012). Adenosine and the VDC 
from oxidative metabolism can also cause membrane 
hyperpolarization and relaxation of vascular smooth 
muscle independently of the endothelium via KATP and 
KV channels on the smooth muscle surface (Deussen et 
al., 2012).
To explore which of these vasodilatory systems are 
involved in the glucose-induced decrease in MBF, we 
infused inhibitors of KATP channels (glibenclamide), 
NO synthase (L-NAME), and COX (indomethacin), 
with and without glucose, into the mammary arterial 
supply. Inhibition of KATP channels with glibenclamide 
had no effect on IPF. Although a decrease in IPF was 
not detected at the onset of glucose infusion in the pres-
ence of glibenclamide, an increase in IPF was detected 
upon cessation of glucose infusion, suggesting that the 
glucose response was not abolished and, therefore, does 
not involve KATP channels.
Indomethacin depresses skeletal muscle blood flow by 
inhibiting PGI2 synthesis in the endothelium and by 
inhibiting mitochondrial respiration in skeletal muscle 
(Boushel et al., 2012). When we infused indomethacin 
into the mammary circulation, we observed a 35% re-
duction in IPF, in agreement with a 40% decrease in 
MBF observed in goats (Nielsen et al., 1995a), which 
suggests a role for PGI2 and the feedforward effects of 
VDC from oxidative metabolism in maintaining MBF. 
However, feedback regulation through adenosine and 
NO is implicated when glucose was included with in-
domethacin and IPF increased instead of decreasing as 
it had without indomethacin. If indomethacin inhibits 
mitochondrial respiration in the mammary glands as in 
skeletal muscle, then the supplemental glucose would 
not be able to increase ADP utilization or production 
of VDC from oxidative metabolism (Figure 7). Only 
anabolic utilization of glucose would be possible, caus-
ing production of ADP and adenosine, which relaxes 
vascular smooth muscle via endothelial NO synthesis 
(Hein and Kuo, 1999; Hellsten et al., 2012). Because 
adenosine and NO synthesis are not inhibited during 
indomethacin infusion, we can infer that they contrib-
uted to the glucose response. Furthermore, this role 
of the feedback regulator of blood flow (adenosine) is 
consistent with the conclusion from glucose infusion, 
without inhibitors, that a feedback mechanism was 
involved.
When IPF was depressed with the NO synthase in-
hibitor L-NAME so that only PGI2 was operative in 
the endothelium, glucose had no effect on blood flow, 
indicating that PGI2 was not involved in the glucose-
induced decrease in MBF. Because PGI2 mediates the 
feedforward effects of energy metabolism on blood flow 
(Thengchaisri and Kuo, 2003; Deussen et al., 2012), 
its lack of participation is consistent with a feedback 
response to glucose. The proposed feedback response 
to glucose occurs through catabolic production of ATP 
that decreases adenosine release into the interstitium 
and thereby deactivates endothelial NO synthase. If the 
L-NAME maximally inhibited NO synthase, then the 
glucose infusion would not be able to further deactivate 
it and IPF would not decrease. The lack of an IPF 
response to glucose during L-NAME infusion is consis-
tent with this feedback role of NO, and not PGI2, in 
nutrient-induced mammary hyperemia.
Link Between MBF and Metabolic Activity
Based on the patterns of IPF observed in our ex-
periments, we propose the model in Figure 7 to link 
metabolic activity in the mammary glands with MBF. 
Nutrients taken into the mammary epithelia from 
blood can be used for both anabolic and catabolic pur-
poses, thereby using and producing ATP, respectively. 
The release of adenosine into the interstitium, where 
it activates endothelial NO synthesis and a consequent 
vascular relaxation, is directly related to intracellular 
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ADP concentration. This relationship completes a feed-
back loop where, if ATP production exceeds utilization, 
adenosine release declines and MBF decreases, and vice 
versa.
Although L-NAME infusion showed that COX was 
not involved in the MBF response to glucose, we can-
not rule out a feedforward mechanism of MBF control 
via COX because indomethacin decreased IPF in our 
study and others (Nielsen et al., 1995a). Furthermore, 
stimulation of mammary activity with growth hormone 
increases PGI2 synthesis and MBF (Christensen et al., 
1989; Nielsen et al., 2004), and a vasodilatory effect of 
CO2 in the mammary vasculature accounts for approxi-
mately one-third of the variation in MBF throughout 
lactation (Nielsen et al., 1995b). In the feedforward 
scenario, VDC are released into the interstitium as 
a result of oxidative catabolism, activating PGI2 and 
NO synthesis in the endothelium and causing vascular 
relaxation.
The IPF responses to glucose infusion show that 
the feedback mechanism of energetic MBF control is 
dominant over the feedforward mechanism. We con-
clude that feedback control should be the mechanism 
described in simulation models to account for variation 
in arterial supply of nutrients to the mammary glands 
and their utilization for milk synthesis.
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